J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM)
1,659.50
-34.50 (-2.04%)
Aug 6, 2025, 3:29 PM IST
NSE:JBCHEPHARM Market Cap
NSE:JBCHEPHARM has a market cap or net worth of 264.56 billion as of August 6, 2025. Its market cap has decreased by -5.92% in one year.
Market Cap
264.56B
Enterprise Value
260.34B
Revenue
40.08B
Ranking
n/a
PE Ratio
38.61
Stock Price
1,659.50
Market Cap Chart
Since December 11, 2001, NSE:JBCHEPHARM's market cap has increased from 408.70M to 264.56B, an increase of 64,631.96%. That is a compound annual growth rate of 31.45%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 6, 2025 | 259.32B | -9.63% |
Dec 31, 2024 | 286.94B | 13.93% |
Dec 29, 2023 | 251.85B | 67.53% |
Dec 30, 2022 | 150.33B | 9.43% |
Dec 31, 2021 | 137.38B | 74.76% |
Dec 31, 2020 | 78.61B | 130.08% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Sun Pharmaceutical Industries | 3,910.20B |
Divi's Laboratories | 1,688.78B |
Cipla | 1,213.89B |
Mankind Pharma | 1,059.19B |
Apollo Hospitals Enterprise | 1,057.03B |
Zydus Lifesciences | 954.97B |
Fortis Healthcare | 648.70B |
Aurobindo Pharma | 627.15B |